Leading Drug Manufacturer Adopts Unified IP Data Model to Develop a Long Term IP Roadmap
Our Client:
Business challenge:
The client did not have accurate data up to 2020, which led to ambiguity in accurately determining the loss of exclusivity (LOE) dates of branded drugs, causing delays in generic drug launches. Also, much effort was wasted on non-value added activities like gathering data pertaining to branded drugs and validating it. Besides, the client faced challenges with process and system inefficiencies in its IP business unit—including non-standard templates and deliverables and unclear roles and responsibilities of IP stakeholders leading to high operating costs.
Solution:
Wipro delivered a unified IP data model to improve data quality and availability with a long term IP roadmap strategy. We also created an IP process document to eliminate overall operational inefficiencies caused due to non-integration of systems, unavailability of accurate data, and inefficient IP processes.
The critical aspects of the solution included:
Business Impact:
Through this program, the client gained the following benefits:
As a result, the client improved its time to market and envisioned risk mitigation strategies for its generic drug launch.
Wipro helps a telecommunication company drive efficiency up through cost optimization
Wipro helps a telecommunications company increase efficiency by reducing errors hrough automation
Wipro helps a telecommunication service provider reduce backlog to a best in class 1%